Skip to search boxSkip to navigationSkip to main content

Interferon γ limits the effectiveness of melanoma peptide vaccines

  • Hyun Il Cho
    ,
  • Young Ran Lee
    ,
  • Esteban Celis(corresponding author)
*Corresponding author for this work
  • University of South Florida
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

The development of effective therapeutic vaccines to generate tumor-reactive cytotoxic T lymphocytes (CTLs) continues to be a top research priority. However, in spite of some promising results, there are no clear examples of vaccines that eradicate established tumors. Most vaccines are ineffective because they generate low numbers of CTLs and because numerous immunosuppressive factors abound in tumor-bearing hosts. We designed a peptide vaccine that produces large numbers of tumor-reactive CTLs in a mouse model of melanoma. Surprisingly, CTL tumor recognition and antitumor effects decreased in the presence of interferon γ (IFNγ), a cytokine that can provide therapeutic benefit. Tumors exposed to IFNγ evade CTLs by inducing large amounts of noncognate major histocompatibility complex class I molecules, which limit T-cell activation and effector function. Our results demonstrate that peptide vaccines can eradicate large, established tumors in circumstances under which the inhibitory activities of IFNγ are curtailed.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 135-144 (10 pages)

Journal (Volume, Issue Number)

Blood (Volume 117, Issue 1)

Publication milestones

  • Published - 01/06/2011

Publication status

Published - 01/06/2011

ISSN

0006-4971

Publication IDs

  • Scopus: 78650983452
  • PubMed: 20889921

Publication metrics

Metrics

Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
1.80
SciVal
Author count
3
SciVal
citations
46
SciVal
Paper percentile
90
SciVal
Top percentile
10
Scopus
citations

PlumX, opens in new tab

Usage
5
Citation count
55
Captures
82

Funding Details

FunderFunding number
NCI
R01CA136828